H
Helix
The leading population genomics company working at the intersection of clinical care, research, and genomics
About Helix
Helix.com is a pioneering startup that operates in the healthcare and life sciences sector, with a focus on genomics. The company's mission is to integrate genomics into the fabric of healthcare, thereby transforming health organizations and fueling their future growth. Helix serves a diverse range of clients, including health systems, public health entities, and life science companies.
Read full description
The company's business model revolves around making genomics accessible and actionable. They provide solutions that enable their clients to deliver personalized and effective healthcare at scale. This not only improves patient outcomes but also reduces costs, thereby creating strategic value for their clients.
Helix also plays a crucial role in the field of medical research, diagnosis, treatment, and prevention. By leveraging the power of genomics, they provide actionable insights that accelerate research and development, reduce costs, and improve outcomes. This helps their clients stay at the forefront of innovation and bring life-changing therapies to market faster.
In addition, Helix operates one of the nation's most expansive clinical Next-Generation Sequencing (NGS) labs. NGS is a high-throughput DNA sequencing technology that enables faster and more efficient genetic analysis. Through their extensive collaborations with healthcare organizations, Helix equips public health entities with cutting-edge genomic technologies and resources. This allows them to push the boundaries of their research, monitor diseases more effectively, and respond to outbreaks more efficiently.
In summary, Helix.com is a dynamic startup that is revolutionizing the healthcare and life sciences sector by making genomics accessible and actionable.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Mateo, United States
- Employees
- 599
- Open positions
- 4
- Dealroom signal
- 83.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, DNA, Genetics and genomics, Genome Engineering, Direct-to-Consumer, Tech for Patients, Rumoured $1B
- Technology
- Big Data
- Business model
- Manufacturing
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Aug 2022
- Capital deployed
- —
- Preferred round
- SERIES A
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jun 2021 | $50M | $1B | Temasek · Mayo Clinic · DFJ Growth · Warburg Pincus | — |
| GRANTOther financing | Jul 2020 | $33M | — | National Institutes of Health | — |
Growth signals
Latest recorded traffic for Helix is 240K monthly website visits, up 41.2% over the last three months. Helix's team grew 7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series A13 investors entered at this stage
Threshold Ventures
Andreessen Horowitz
Obvious Ventures- BVBorealis Ventures
Illumina
Warburg Pincus
Sutter Hill Ventures
Mayo Clinic
LaunchCapital
Kleiner Perkins
Casdin Capital
DFJ Growth
Temasek
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Helix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Helix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








